Korea Pilot Study

Completed Clinical Trial (First-in-man study)

DENEX has demonstrated superb efficacy and safety in pilot study.

Enrollment 16 participants.
Allocation N/A (Single-Arm).
Masking None (Open Label).
# of trial centers 4 (multi).
Inclusion criteria Office SBP > 150 mmHg.
Daytime AMSBP > 140 mmHg.
> 3 anti-HTN meds incl. diuretics.
Safety issue None
Procedure time 20.3 + 10.9 minutes
(Min. 12 minutes, Max. 45 minutes).
DENEX Pilot Study: NCT04248530
Learn More
Graph Image